Qube Research & Technologies Ltd - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 42 filers reported holding THERAPEUTICSMD INC in Q1 2024. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q2 2024$4
-20.0%
20.0%0.00%
Q1 2024$50.0%20.0%0.00%
Q4 2023$5
-16.7%
20.0%0.00%
Q3 2023$6
-100.0%
2
-100.0%
0.00%
-100.0%
Q2 2022$219,00022,0550.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2024
NameSharesValueWeighting ↓
Rubric Capital Management LP 1,156,953$7,682,0000.39%
SANDERS MORRIS HARRIS LLC 40,393$268,0000.07%
XR Securities LLC 41,200$63,0000.03%
State of Wyoming 8,797$58,0000.03%
J. Goldman & Co LP 82,976$551,0000.03%
Asset Management Group, Inc. 14,701$98,0000.02%
EQUITEC PROPRIETARY MARKETS, LLC 12,000$80,0000.02%
EQUITEC PROPRIETARY MARKETS, LLC 9,100$60,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 38,042$253,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 15,000$100,0000.00%
View complete list of THERAPEUTICSMD INC shareholders